TCS Ranked as the #1 Life Sciences Service Provider by HFS
TCS has been ranked #1 in the HFS Top 10 Life Sciences Service Providers Report 2019. This report highlights TCS’ strong domain expertise across the life sciences value chain, as a key strength. It goes on to say that TCS’ IP-led go-to-market approach that allows it to capture emerging opportunities in genomics, bio-informatics, connected devices, and 3-D printing by leveraging the TCS COIN ecosystem, was cited as a strength. The report also highlights TCS’ Digital platforms for life sciences, including the award-winning TCS Advanced Drug Development (ADD) platform suite, the Decision FabricTM engine, TCS Connected Clinical TrialsTM and Cognitive Commercial Intelligence (CCI) Platform.
"The role of third-party service providers in the life sciences industry is no longer just supporting "business-as-usual", but to help enterprises drive "meaningful change." With investments in platforms such as TCS - ADD Suite of platforms, Connected Clinical TrialsTM (CCT) platform, and Cognitive Commercial Intelligence Platform, TCS brings to the table an IP-focused and platform-based offering set backed by strong domain expertise to do just that.” said, Saurabh Gupta, Chief Research Officer, HFS Research.
TCS works with leading life sciences companies to accelerate their business transformation journey by leveraging its Business 4.0TM framework and Machine First™ Delivery Model (MFDMTM). TCS offers a full set of IT and business process capabilities including regulatory services, predictive and prescriptive analytics, genomics research, advanced platform solutions for the entire clinical R&D value chain, medical device engineering, supply chain and manufacturing and sales and marketing. TCS ADD is a suite of cloud-based platforms that leverage next-gen digital technologies such as automation, AI, and IoT to transform the entire clinical R&D value chain. TCS’ CCI platform provides transformational and flexible analytics solutions to help the sales, marketing, pricing and market access functions within life sciences organizations make smarter decisions at scale. The TCS Real World Evidence platform provides end-to-end value evidence lifecycle management capabilities including real world data, knowledge and evidence management, study conduct and management, evidence generation and synthesis and value communication.